172 related articles for article (PubMed ID: 26518164)
41. [Effect of CCR1 gene overexpression on the migration of bone marrow - derived mesenchymal stem cells towards hepatocellular carcinoma].
Gao Y; Huang XL; Zhang L; Deng L; Yin AH; Sun BC; Lu S
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):354-359. PubMed ID: 28763842
[No Abstract] [Full Text] [Related]
42. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
[TBL] [Abstract][Full Text] [Related]
43. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
Park MY; Park YS; Nam JH
Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
[TBL] [Abstract][Full Text] [Related]
44. Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.
Zhang Q; Yuan XF; Lu Y; Li ZZ; Bao SQ; Zhang XL; Yang YY; Fan DM; Zhang YZ; Wu CX; Guo HX; Zhang YJ; Ye Z; Xiong DS
Int J Cancer; 2017 Oct; 141(7):1445-1457. PubMed ID: 28643325
[TBL] [Abstract][Full Text] [Related]
45. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
[TBL] [Abstract][Full Text] [Related]
46. Enhanced expression of HLA class I molecules in human hepatocellular carcinoma cells transduced with gamma-interferon gene.
Qian S; Zhang T; Chen S
Chin Med J (Engl); 1998 Apr; 111(4):319-22. PubMed ID: 10374395
[TBL] [Abstract][Full Text] [Related]
47. Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.
Mohamed FE; Al-Jehani RM; Minogue SS; Andreola F; Winstanley A; Olde Damink SW; Habtesion A; Malagó M; Davies N; Luong TV; Dhillon AP; Mookerjee RP; Dhar DK; Jalan R
Liver Int; 2015 Mar; 35(3):1063-76. PubMed ID: 24990399
[TBL] [Abstract][Full Text] [Related]
48. Effects of IFN-alpha on alpha-fetoprotein expressions in hepatocellular carcinoma cells.
Yano H; Basaki Y; Oie S; Ogasawara S; Momosaki S; Akiba J; Nishida N; Kojiro S; Ishizaki H; Moriya F; Kuratomi K; Fukahori S; Kuwano M; Kojiro M
J Interferon Cytokine Res; 2007 Mar; 27(3):231-8. PubMed ID: 17348822
[TBL] [Abstract][Full Text] [Related]
49. Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice.
Roh MR; Zheng Z; Kim HS; Jeung HC; Rha SY; Chung KY
Melanoma Res; 2013 Apr; 23(2):114-24. PubMed ID: 23358428
[TBL] [Abstract][Full Text] [Related]
50. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
51. Effect of adipose-derived mesenchymal stem cells on hepatocellular carcinoma:
Serhal R; Saliba N; Hilal G; Moussa M; Hassan GS; El Atat O; Alaaeddine N
World J Gastroenterol; 2019 Feb; 25(5):567-583. PubMed ID: 30774272
[TBL] [Abstract][Full Text] [Related]
52. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
53. Effect of bone-marrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: an intervention study.
Li T; Song B; Du X; Wei Z; Huo T
Eur J Med Res; 2013 Sep; 18(1):34. PubMed ID: 24079479
[TBL] [Abstract][Full Text] [Related]
54. Effect of mesenchymal stem cells and a novel curcumin derivative on Notch1 signaling in hepatoma cell line.
Abdel Aziz MT; Khaled HM; El Hindawi A; Roshdy NK; Rashed LA; Sabry D; Hassouna AA; Taha F; Ali WI
Biomed Res Int; 2013; 2013():129629. PubMed ID: 24024180
[TBL] [Abstract][Full Text] [Related]
55. Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers.
Iqbal Ahmed CM; Johnson DE; Demers GW; Engler H; Howe JA; Wills KN; Wen SF; Shinoda J; Beltran J; Nodelman M; Machemer T; Maneval DC; Nagabhushan TL; Sugarman BJ
Cancer Gene Ther; 2001 Oct; 8(10):788-95. PubMed ID: 11687902
[TBL] [Abstract][Full Text] [Related]
56. The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-β on tongue squamous cell carcinoma cells and xenograft model.
Du L; Liang Q; Ge S; Yang C; Yang P
Stem Cell Res Ther; 2019 Jul; 10(1):224. PubMed ID: 31358054
[TBL] [Abstract][Full Text] [Related]
57. Aspirin promotes bone marrow mesenchymal stem cell-based calvarial bone regeneration in mini swine.
Cao Y; Xiong J; Mei S; Wang F; Zhao Z; Wang S; Liu Y
Stem Cell Res Ther; 2015 Oct; 6():210. PubMed ID: 26519141
[TBL] [Abstract][Full Text] [Related]
58. Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.
Xiao Z; Chung H; Banan B; Manning PT; Ott KC; Lin S; Capoccia BJ; Subramanian V; Hiebsch RR; Upadhya GA; Mohanakumar T; Frazier WA; Lin Y; Chapman WC
Cancer Lett; 2015 May; 360(2):302-9. PubMed ID: 25721088
[TBL] [Abstract][Full Text] [Related]
59. Adipose Tissue-Derived Mesenchymal Stem Cells Suppress Growth of Huh7 Hepatocellular Carcinoma Cells via Interferon (IFN)-β-Mediated JAK/STAT1 Pathway
Byun CS; Hwang S; Woo SH; Kim MY; Lee JS; Lee JI; Kong JH; Bae KS; Park IH; Kim SH; Eom YW
Int J Med Sci; 2020; 17(5):609-619. PubMed ID: 32210710
[TBL] [Abstract][Full Text] [Related]
60. Superior Antitumor Efficacy of IFN-α2b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer.
Liu Q; Zhang D; Qian H; Chu Y; Yang Y; Shao J; Xu Q; Liu B
Int J Nanomedicine; 2020; 15():3669-3680. PubMed ID: 32547021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
